Nanomedicine enables efficient CRISPR-Cas9 genome editing for disease treatment
Sci Bull (Beijing)
.
2022 Mar 30;67(6):572-576.
doi: 10.1016/j.scib.2021.11.016.
Epub 2021 Nov 20.
Authors
Lifang Ma
1
,
Caihong Dong
2
,
Meihua Yu
3
,
Xinran Song
4
,
Yongchun Yu
5
,
Yu Chen
6
Affiliations
1
Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China; Department of Clinical Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China.
2
Department of Ultrasound, Zhongshan Hospital, Fudan University, and Shanghai Institute of Medical Imaging, Shanghai 200032, China.
3
Materdicine Laboratory, School of Life Sciences, Shanghai University, Shanghai 200444, China. Electronic address: myu@shu.edu.cn.
4
Materdicine Laboratory, School of Life Sciences, Shanghai University, Shanghai 200444, China.
5
Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China. Electronic address: yyc2166@sjtu.edu.cn.
6
Materdicine Laboratory, School of Life Sciences, Shanghai University, Shanghai 200444, China. Electronic address: chenyuedu@shu.edu.cn.
PMID:
36546116
DOI:
10.1016/j.scib.2021.11.016
No abstract available
MeSH terms
CRISPR-Cas Systems* / genetics
Gene Editing*
Humans
Nanomedicine
Palliative Care